Categories
Publications & Presentations
Discover the main highlights of our industry in our latest publications.
Access to Care
Discover a complete record of access to care issues by region and PPTA activities in support of access to therapies.
Safety & Quality
Learn more about the regulatory policies and the Association’s voluntary standards for safety & quality standards.
Plasma Collection & Manufacturing
Learn more about plasma collection and discover certified plasma centers near you.
The Source Magazine
Subscribe to the international magazine of the plasma protein therapeutics industry.
Plasma FAQS
Get answers about plasma therapies and the processes surrounding donation and collection procedures.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Nov 8, 2023
Summary of the PPTA/FDA Liaison Meeting (November 8, 2023)
PDMPs — which are derived from human plasma from healthy donors — are essential for around 300,000 European patients who rely on these therapies to treat a variety of rare, chronic, and potentially life-threatening conditions, which are often genetic in origin. Without these treatments, many patients might not survive or would have a substantially diminished quality of life. In addition, plasma-derived medicines are also used in everyday treatment, such as supportive treatment in trauma cases, liver disease, cardiac surgery, and in some cases, pregnancy complications.
All
PPTA statements
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/657b49c161b36be580c14e84_2023%20FDA%20Liaison%20Meeting%20Summary_Website_FINAL.pdf
Nov 8, 2023
Summary of the PPTA/FDA Liaison Meeting (November 8, 2023)
PDMPs — which are derived from human plasma from healthy donors — are essential for around 300,000 European patients who rely on these therapies to treat a variety of rare, chronic, and potentially life-threatening conditions, which are often genetic in origin. Without these treatments, many patients might not survive or would have a substantially diminished quality of life. In addition, plasma-derived medicines are also used in everyday treatment, such as supportive treatment in trauma cases, liver disease, cardiac surgery, and in some cases, pregnancy complications.
All
PPTA statements
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/657b49c161b36be580c14e84_2023%20FDA%20Liaison%20Meeting%20Summary_Website_FINAL.pdf
Nov 1, 2023
A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time
All
Blog Posts
Nov 1, 2023
A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time
All
Blog Posts
Oct 27, 2023
PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation
All
PPTA statements
Oct 27, 2023
PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation
All
PPTA statements
Sep 26, 2023
The Source Fall 2023
Magazine of the plasma protein therapeutics industry - Fall 2023
All
The Source Magazine
https://spaces.hightail.com/receive/bRmBuSpJRl
Sep 26, 2023
The Source Fall 2023
Magazine of the plasma protein therapeutics industry - Fall 2023
All
The Source Magazine
https://spaces.hightail.com/receive/bRmBuSpJRl
No results found